Drug Holidays in the Treatment With Alendronate in Postmenopausal Women With Osteoporosis
NCT ID: NCT00936260
Last Updated: 2009-07-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
228 participants
INTERVENTIONAL
1998-01-31
2004-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Osteoporosis Prevention With Low Dose Alendronate
NCT00463268
Bone Effects of Teriparatide Following Alendronate
NCT00191893
Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis
NCT00000430
A Clinical Study on the Effect of Discontinuing Alendronate in Postmenopausal Women With Osteoporosis After a Treatment Period Without Fractures
NCT06864130
A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED)
NCT00398606
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
alendronate 6 years
alendronate
several duration of treatment
alendronate 5 years
No treatment during year 6th
alendronate
several duration of treatment
alendronate 5 years, not continued
No treatment during year 5th
alendronate
several duration of treatment
alendronate 4 years
No treatment during year 5th and 6th
alendronate
several duration of treatment
alendronate 5 years, uncontinued
No treatment during year 4th
alendronate
several duration of treatment
alendronate 4 years, not continued
No treatment during year 4th and 6th
alendronate
several duration of treatment
alendronate 4 years, uncontinued
No treatment during year 4th and 5th
alendronate
several duration of treatment
Alendronato 3 years
No treatment during the last 3 years
alendronate
several duration of treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
alendronate
several duration of treatment
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* alteration in analytic parameters (total proteins, calcium, phosphorus, vitamin D, parathyroid hormone, thyroid hormone, transaminase, creatinine)
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ciudad Universitaria, Spain
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University San Carlos Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carlos Lozano Tonkin, doctor
Role: STUDY_DIRECTOR
university san carlos hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University San Carlos Hospital
Madrid, Madrid, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
individual reseacher
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.